Innovative Targeting Strategies in Breast Cancer Therapy is a comprehensive reference addressing the challenge of non-specific drug distribution in the body, along with severe toxicity and adverse effects, by offering insights into targeted breast cancer treatment. It further educates researchers on formulating and developing novel carriers with target-specific attributes (such as targeted liposomes, nanoparticles, micelles, and dendrimers), contributing to a more refined approach to breast cancer. This book's content is presented in 12 chapters. The first chapters introduces the reader to the different breast cancer therapies followed by indepth information on targeting . Recognizing the need for targeted drug delivery in breast cancer treatment, this book presents an encompassing compilation of advanced research and formulation strategies. By focusing on effectively targeting cancer cells, the book mitigates dose-related toxicity associated with cytotoxic drugs, providing a comprehensive resource for improved treatment approaches. Research in oncology, pharmacology, medical researchers, biomedical engineers and clinical professionals will find this an essential reference.
1. Cover image - p. c 2. Title page - p. iii 3. Copyright - p. iv 4. Table of Contents - p. v 5. Contributors - p. xiii 6. Chapter 1 Chemotherapeutic drugs and their side effects, BC biomarkers, detection, levels of targeting, and EPR - p. 1 7. Chapter 2 Receptor-ligand-based targeting approaches in breast cancer - p. 35 8. Chapter 3 Stimuli-based targeting to breast cancer - p. 65 9. Chapter 4 Advanced strategies for targeting severe triple-negative breast cancer - p. 85 10. Chapter 5 Targeted therapy for BRCA gene mutations breast cancer - p. 119 11. Chapter 6 Androgen receptor targeted therapy for breast cancer - p. 137 12. Chapter 7 Monoclonal antibody based breast cancer targeting - p. 163 13. Chapter 8 Breast cancer stem cell targeting - p. 197 14. Chapter 9 The role of hormone receptors in breast cancer: New opportunities for treatment and prevention - p. 229 15. Chapter 10 HER2-positive (HER2+) & HER2-negative (HER2−) targeted therapies - p. 257 16. Chapter 11 Immunotherapy for breast cancer - p. 285 17. Chapter 12 Breast cancer therapeutics: Market dynamics, clinical trial progress, and intellectual property overview - p. 305 18. Index - p. 325
Innovative Targeting Strategies in Breast Cancer Therapy is a comprehensive reference addressing the challenge of non-specific drug distribution in the body, along with severe toxicity and adverse effects, by offering insights into targeted breast cancer treatment. It further educates researchers on formulating and developing novel carriers with target-specific attributes (such as targeted liposomes, nanoparticles, micelles, and dendrimers), contributing to a more refined approach to breast cancer. This book's content is presented in 12 chapters. The first chapters introduces the reader to the different breast cancer therapies followed by indepth information on targeting . Recognizing the need for targeted drug delivery in breast cancer treatment, this book presents an encompassing compilation of advanced research and formulation strategies. By focusing on effectively targeting cancer cells, the book mitigates dose-related toxicity associated with cytotoxic drugs, providing a comprehensive resource for improved treatment approaches. Research in oncology, pharmacology, medical researchers, biomedical engineers and clinical professionals will find this an essential reference.
1. Cover image - p. c 2. Title page - p. iii 3. Copyright - p. iv 4. Table of Contents - p. v 5. Contributors - p. xiii 6. Chapter 1 Chemotherapeutic drugs and their side effects, BC biomarkers, detection, levels of targeting, and EPR - p. 1 7. Chapter 2 Receptor-ligand-based targeting approaches in breast cancer - p. 35 8. Chapter 3 Stimuli-based targeting to breast cancer - p. 65 9. Chapter 4 Advanced strategies for targeting severe triple-negative breast cancer - p. 85 10. Chapter 5 Targeted therapy for BRCA gene mutations breast cancer - p. 119 11. Chapter 6 Androgen receptor targeted therapy for breast cancer - p. 137 12. Chapter 7 Monoclonal antibody based breast cancer targeting - p. 163 13. Chapter 8 Breast cancer stem cell targeting - p. 197 14. Chapter 9 The role of hormone receptors in breast cancer: New opportunities for treatment and prevention - p. 229 15. Chapter 10 HER2-positive (HER2+) & HER2-negative (HER2−) targeted therapies - p. 257 16. Chapter 11 Immunotherapy for breast cancer - p. 285 17. Chapter 12 Breast cancer therapeutics: Market dynamics, clinical trial progress, and intellectual property overview - p. 305 18. Index - p. 325
